Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

RSPH vs. RYHIX: which is better?

Bottom line

RSPH vs RYHIX: the short answer

RSPH (Invesco S&P 500 Equal Weight Health Care ETF) and RYHIX (Health Care Fund) are quite different portfolios: only about 21% of their top holdings (by weight) are shared.

But RYHIX is far broader, holding 135 positions to 63 for RSPH, so beyond the top names it adds exposure RSPH doesn't have.

RSPH is cheaper at 0.4% vs 1.38% — a difference of $98 a year per $10,000 invested.

Over five years, RYHIX returned +5.1% a year vs +4.7% for RSPH.

Updated Nov 19, 2026

RSPH vs RYHIX side by side

RSPHRYHIX
TypeETFMutual fund
Fund familyInvescoGuggenheim
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.4%1.38%
Annual cost per $10k$40$138
10-yr cost on $10k (prospectus)$505$1,709
Max front loadNone—
12b-1 fee—0%
1-yr return+9.3%+14.4%
5-yr return (annualized)+4.7%+5.1%
10-yr return (annualized)+8.2%+7.9%
Best quarter+17.5%+18.7%
Worst quarter−14.3%−14.4%
Net assets (fund)$766.9M$19.4M
Number of holdings63135
Portfolio turnover24%244%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearRSPHRYHIXDifference
2025+9.3%+14.4%−5.1%
2024−0.8%+0.6%−1.4%
2023+3.9%+5.8%−1.9%
2022−9.2%−11.6%+2.4%
2021+23.0%+19.2%+3.8%
2020+18.9%+18.9%−0.0%
2019+25.3%+22.8%+2.6%
2018−0.3%+1.6%−1.9%
2017+23.4%+23.5%−0.1%
2016−4.5%−9.4%+4.9%

Source: Fund prospectus bar charts

Holdings overlap

6 of RSPH's top 25 holdings also appear in RYHIX's top 25.

Shared top holdings
HoldingRSPHRYHIX
Regeneron Pharmaceuticals, Inc.1.96%0.90%
Thermo Fisher Scientific Inc.1.84%1.61%
Abbott Laboratories1.83%1.42%
Bristol-Myers Squibb Co.1.82%1.22%
Amgen Inc.1.77%1.56%
AbbVie Inc.1.73%2.52%

Source: SEC Form N-PORT

RSPH top 10

  1. Bio-Techne Corp. — 2.13%
  2. IQVIA Holdings Inc. — 2.00%
  3. Baxter International Inc. — 1.99%
  4. Regeneron Pharmaceuticals, Inc. — 1.96%
  5. Mettler-Toledo International Inc. — 1.94%
  6. Charles River Laboratories International, Inc. — 1.93%
  7. Veeva Systems Inc. — 1.93%
  8. DaVita Inc. — 1.87%
  9. Moderna, Inc. — 1.85%
  10. Thermo Fisher Scientific Inc. — 1.84%

RYHIX top 10

  1. Eli Lilly & Company — 3.63%
  2. Johnson & Johnson — 2.88%
  3. Abbvie Inc — 2.52%
  4. Unitedhealth Group Inc — 2.22%
  5. Merck & Company Inc — 2.04%
  6. Thermo Fisher Scientific Inc — 1.61%
  7. Amgen Inc — 1.56%
  8. Abbott Laboratories — 1.42%
  9. Gilead Sciences Inc — 1.39%
  10. Vertex Pharmaceuticals Inc — 1.34%

FAQ

What is the difference between RSPH and RYHIX?
RSPH (Invesco S&P 500 Equal Weight Health Care ETF) and RYHIX (Health Care Fund) are quite different portfolios: only about 21% of their top holdings (by weight) are shared. But RYHIX is far broader, holding 135 positions to 63 for RSPH, so beyond the top names it adds exposure RSPH doesn't have.
Which is cheaper, RSPH or RYHIX?
RSPH has the lower expense ratio (0.4%).
Should I own both RSPH and RYHIX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.